E. Ohman J or Asset Management AB Sells 157,152 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

E. Ohman J or Asset Management AB decreased its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 12.6% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,085,959 shares of the company's stock after selling 157,152 shares during the period. E. Ohman J or Asset Management AB owned approximately 0.85% of Surgery Partners worth $25,792,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. KBC Group NV boosted its stake in shares of Surgery Partners by 66.1% in the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares in the last quarter. State of Wyoming boosted its stake in shares of Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after purchasing an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its stake in shares of Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after purchasing an additional 465 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Surgery Partners by 7,902.7% in the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock valued at $211,000 after purchasing an additional 8,772 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC boosted its stake in shares of Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after purchasing an additional 1,460 shares in the last quarter.

Surgery Partners Trading Up 0.1%

NASDAQ:SGRY traded up $0.02 during midday trading on Friday, reaching $23.19. 567,111 shares of the stock traded hands, compared to its average volume of 1,112,864. The company has a fifty day moving average of $22.27 and a 200 day moving average of $22.76. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The stock has a market capitalization of $2.97 billion, a P/E ratio of -48.31, a PEG ratio of 19.21 and a beta of 1.93.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $776.00 million during the quarter, compared to the consensus estimate of $777.77 million. During the same quarter last year, the company posted $0.10 earnings per share. The firm's revenue for the quarter was up 8.2% compared to the same quarter last year. On average, research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Analyst Upgrades and Downgrades

SGRY has been the subject of a number of research reports. Barclays cut their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 27th. Macquarie cut their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Benchmark reiterated a "buy" rating and set a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $35.00 price target on shares of Surgery Partners in a report on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.56.

Insiders Place Their Bets

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the transaction, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72. This represents a 4.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO David T. Doherty sold 6,733 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the transaction, the chief financial officer now owns 150,868 shares of the company's stock, valued at $3,623,849.36. This trade represents a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.30% of the company's stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.